The CBFA2T3 gene helps control when other genes are switched on or off, especially during blood cell development. This gene plays an important role in helping immature bone marrow cells mature in an orderly way. If it does not work normally, cell growth and maturation can become unbalanced. In some blood cancers, part of the CBFA2T3 gene becomes joined to another gene, which is linked to certain childhood leukemias.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for making proteins, the molecules that do the work inside cells. Others mainly help determine when certain processes happen, where they happen, and how strongly they occur. As a group, genes influence how the body develops and works, and they can shape how you respond to food, stress, or medications. To explore this subject in greater depth, you can find more in the LearnHub.
Overview
CBFA2T3Gene function
What if the gene works
The CBFA2T3 gene helps control when other genes turn on or off, especially during blood cell development. Its protein helps young blood cells mature in a controlled way.
Risk
What if the gene does not work
When the CBFA2T3 gene works less well, cells may lose part of a protein that helps switch other genes off during blood cell development. Milder and more severe variants can reduce this control by different amounts.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to the CBFA2T3 gene is currently established for pathogenic or loss of function variants in this gene. In research, altered CBFA2T3 is studied mainly as a biomarker and as part of fusion genes in some leukemias, rather than as a direct treatment target.
Conditions associated with CBFA2T3
Gene function
What if the gene works
Cells use the CBFA2T3 gene to keep gene activity organized. Its main job is to help decide when certain instructions should be turned down, especially during blood cell development. When it works normally, growing cells can follow a steadier path as they mature. This is part of how the CBFA2T3 gene helps control blood cell development.
The CBFA2T3 gene helps cells turn down selected genes at the right time. It works with proteins that attach near genes, so cells use the right instructions for each stage of growth.
Its protein acts as a meeting point for several gene control proteins. This lets cells coordinate larger gene programs, so groups of instructions are adjusted together instead of one by one.
In cells that make blood, the CBFA2T3 gene supports orderly growth and maturation. This helps young blood cells move through normal stages as they specialize into different cell types.
Proper activity of the CBFA2T3 gene helps cells keep a stable pattern of gene use. This supports each cell’s role, so it can keep behaving like the type of cell it is meant to be.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent the natural range of genetic variation. Sometimes, though, a variant changes gene function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CBFA2T3 gene can change the shape or stability of its protein, so it may not bind partner proteins normally or control gene switching in a balanced way. This is the main pattern behind how CBFA2T3 gene variants affect protein function: milder changes may partly reduce activity, while more disruptive variants can shorten the protein or leave little usable protein in the cell. These differences create a spectrum of functional impact.
How variants are linked to conditions
Changes involving the CBFA2T3 gene are most clearly linked to certain blood cancers, especially childhood acute megakaryoblastic leukemia. In CBFA2T3 gene changes in leukemia, doctors often mean an acquired gene fusion such as CBFA2T3::GLIS2 found in the cancer cells rather than an inherited family trait. This finding helps classify the leukemia and is associated with a higher likelihood of a more challenging course.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen in the general population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CBFA2T3 gene. If CBFA2T3 is being discussed in your care, a doctor or genetic counselor can help explain what it may mean for your personal risk.
Inheritance of CBFA2T3 variants
There is not yet a broadly confirmed Mendelian pattern that explains how CBFA2T3 gene variants are inherited in a specific inherited condition, and this picture may become clearer as research develops. The CBFA2T3 gene is located on chromosome 16, which is an autosome. That means every person inherits one copy of the CBFA2T3 gene from each parent, and inheritance is not expected to differ between sons and daughters.
What does my CBFA2T3 result mean for my family?
There isn’t yet a broadly confirmed inherited pattern tied to a specific health condition for CBFA2T3, and this gene is more often discussed in changes that happen only in blood or tumor cells rather than changes passed through a family. If you have a specific CBFA2T3 result and questions about relatives, a doctor or genetic counselor can explain what that exact finding may mean for your family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CBFA2T3 gene, CBFA2T3 genetic testing reads DNA from a blood, saliva, bone marrow, or tumor sample. Depending on the reason for testing, the lab may sequence the gene and also look for larger rearrangements, including gene fusions.
When should I consider getting a genetic test?
Testing for CBFA2T3 is usually considered when doctors are checking blood or bone marrow for leukemia, especially some forms of childhood acute myeloid leukemia. In this setting, they are usually looking for changes in the leukemia cells themselves, not an inherited gene change passed down through a family.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they reveal varies by the condition and the kind of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This is a common reason why the same medication may work well for one person, work less well for another, or cause more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape a person’s response to medication. It examines relationships between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body processes it. This understanding can help support more informed, more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CBFA2T3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about symptoms, treatment, or side effects are best discussed with your doctor.
History
In the late 1990s, researchers identified the CBFA2T3 gene as part of a small family of genes related to RUNX1T1, a gene already known from leukemia research. From these first observations, research expanded steadily. Scientists later linked CBFA2T3 to chromosome rearrangements seen in some blood cancers, which brought the gene into cancer genetics studies. A notable step came when a CBFA2T3-GLIS2 fusion was described in children with acute megakaryoblastic leukemia, helping define a distinct leukemia subgroup. Over time, descriptions became more precise as laboratory methods improved and gene sequencing became routine. Today, CBFA2T3 is mainly recognized in hematology research for its role in the history of leukemia classification.